Treatment of essential tremor: A systematic review of evidence and recommendations from the Italian Movement Disorders Association

Journal of Neurology

Volumn 260, Issue 3, 2013, Pages 714-740

  Zappia, Mario ^a   Albanese, Alberto ^b,c   Bruno, Elisa ^a   Colosimo, Carlo ^d   Filippini, Graziella ^b   Martinelli, Paolo ^e   Nicoletti, Alessandra ^a   Quattrocchi, Graziella ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Essential tremor; Recommendations; Systematic review; Treatment

Indexed keywords

ALPRAZOLAM; AMANTADINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; AROTINOLOL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; BUFETOLOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CLOZAPINE; GABAPENTIN; INDENOLOL; ISONIAZID; LEVODOPA; METOPROLOL; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; OXPRENOLOL; PINDOLOL; PRIMIDONE; PROPRANOLOL; SOTALOL; SPIRENDOLOL; TIMOLOL; TOPIRAMATE; UNINDEXED DRUG; ZONISAMIDE;

ABSENCE OF SIDE EFFECTS; ACCELEROMETER; AGRANULOCYTOSIS; ANXIETY; ATAXIA; BALANCE DISORDER; BLOOD PRESSURE; BLURRED VISION; BRADYCARDIA; BRAIN DEPTH STIMULATION; BREATHING RATE; CONCENTRATION LOSS; CONFUSION; DECREASED APPETITE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSARTHRIA; ESSENTIAL TREMOR; FAINTNESS; FATIGUE; GAMMA KNIFE RADIOSURGERY; GASTROINTESTINAL DISEASE; HEADACHE; HEMATOMA; HUMAN; HYPOTENSION; INSOMNIA; LETHARGY; LONG TERM CARE; LOW DRUG DOSE; MEMORY DISORDER; MUSCLE WEAKNESS; NAUSEA; NERVOUSNESS; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARESTHESIA; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PULSE RATE; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SUBTHALAMIC NUCLEUS; SYSTEMATIC REVIEW; TACHYCARDIA; TASTE DISORDER; THALAMOTOMY; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VERTIGO; VOMITING; WEAKNESS; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

EID: 84876491219     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6628-x     Document Type: Review

References (176)

1. Louis ED, Ottman R, Hauser WA (1998) How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord 13(1):5-10
2. Louis ED (2001) Clinical practice. Essential tremor. N Engl J Med 345(12):887-891
3. Jankovic J (2002) Essential tremor: a heterogenous disorder. Mov Disord 17(4):638-644
4. Koller W, Biary N, Cone S (1986) Disability in essential tremor: effect of treatment. Neurology 36(7):1001-1004
5. Busenbark KL, Nash J, Nash S, Hubble JP, Koller WC (1991) Is essential tremor benign? Neurology 41(12):1982-1983
6. Deuschl G, Koller WC (2000) Introduction. Essential tremor. Neurology 54(11 Suppl 4):S1
7. Zesiewicz TAE, R. Louis ED, Hauser RA, Sullivan KL, Dewey RB Jr, Ondo WG, Gronseth GS, Weiner WJ, Quality Standard Subcommittee of the American Academy of Neurology (2005) Practice parameter: therapies for essential tremor: report of the quality standards subcommittee of the American Academy of Neurology. Neurology 64(12):2008-2020
8. Hansten PDHJIWR, O'Dell JA (2004) Managing clinically important drug interactions. Facts & Comparisons, St. Louis
9. Evidente VG (2000) Understanding essential tremor: differential diagnosis and options for treatment. Postgrad Med 108(5):138-140, 143-136, 149
10. Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr et al (2011) Evidence-based guideline update: treatment of essential tremor: report of the quality standards subcommittee of the American Academy of Neurology. Neurology 77:1752-1755
11. Deuschl G, Raethjen J, Hellriegel H, Elble R (2011) Treatment of patients with essential tremor. Lancet Neurol 10:148-161
12. Bain P, Brin M, Deuschl G, Elble R, Jankovic J, Findley L et al (2000) Criteria for the diagnosis of essential tremor. Neurology 54(11 Suppl 4):S7
13. Chouinard S, Louis ED, Fahn S (1997) Agreement among movement disorder specialists on the clinical diagnosis of essential tremor. Mov Disord 12(6):973-976
14. Louis ED, Ford B, Lee H, Andrews H, Cameron G (1998) Diagnostic criteria for essential tremor: a population perspective. Arch Neurol 55(6):823-828
15. Deuschl G, Bain P, Brin M (1998) Consensus statement of the movement disorder society on tremor. Mov Disord 13(S3):2-23
16. Higgins JPT GS (2009) Cochrane handbook for systematic reviews of interventions version 5.0.2 (updated Sept 2009)
17. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist GE, Brozek J et al (2010) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383-394
18. Fahn ST, Marin EC (2004) The tremor rating scale (TRS). Mov Disord 19:1131-1132
19. Finldey LK, Koller WC (1995) Definitions and behavioural classifications. Handbook of tremor disorders, New York
20. Bain PG, Findley LJ, Atchison P, Behari M, Vidailhet M, Gresty M et al (1993) Assessing tremor severity. J Neurol Neurosurg Psychiatry 56(8):868-873
21. Louis ED, Yousefzadeh E, Barnes LF, Yu Q, Pullman SL, Wendt KJ (2000) Validation of a portable instrument for assessing tremor severity in epidemiologic field studies. Mov Disord 15(1):95-102
22. Louis ED, Ottman R, Ford B, Pullman S, Martinez M, Fahn S et al (1997) The Washington Heights-Inwood genetic study of essential tremor: methodologic issues in essential-tremor research. Neuroepidemiology 16(3):124-133
23. Elble R, Pullman S, Matsumoto JY, Raethjen J, Deuschl G, Tintner R (2006) Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain 129:2660-2666
24. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A (2011) GRADE guidelines: a new series of articles in the journal of clinical epidemiology. J Clin Epidemiol 64(4):380-382
25. Costa DJ, Bousquet PJ, Ryan D, Price D, Demoly P, Brozek J et al (2009) Guidelines for allergic rhinitis need to be used in primary care. Prim Care Respir J 18(4):250-257
26. Tolosa ES, Loewenson RB (1975) Essential tremor: treatment with propranolol. Neurology 25(11):1041-1044
27. Findley LJ, Calzetti S, Gresty MA, Paul EA (1981) Amplitude of benign essential tremor and response to propranolol. Lancet 2(8244):479-480
28. Calzetti S, Findley L, Gresty M, Perucca E, Richens A (1981) Metoprolol and propranolol in essential tremor: a double-blind, controlled study. J Neurol Neurosurg Psychiatry 44:814-819
29. Serrano-Duenas M (2003) Clonidine versus propranolol in the treatment of essential tremor: a double-blind trial with a one-year follow-up. Neurologia 18(5):248-254
30. Koller WC, Vetere-Overfield B (1989) Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 39(12):1587-1588
31. Murray TJ (1972) Treatment of essential tremor with propranolol. Can Med Assoc J 107(10):984-986
32. Kuroda Y, Kakigi R, Shibasaki H (1988) Treatment of essential tremor with arotinolol. Neurology 38(4):650-652
33. Troiano AR, Teive HA, Fabiani GB, Zavala JA, Sa DS, Germiniani FM et al (2004) Clinical response to long-action propranolol in 40 patients diagnosed with essential tremor with no previous treatment: an open, non-controlled study. Arq Neuropsiquiatr 62(1):86-90
34. Calzetti S, Sasso E, Baratti M, Fava R (1990) Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor. Acta Neurol Scand 81:392-396
35. Teravainen H, Larsen A, Fogelholm R (1977) Comparison between the effects of pindolol and propranolol on essential tremor. Neurology 27(5):439-442
36. Ogawa N, Takayama H, Yamamoto M (1987) Comparative studies on the effects of beta-adrenergic blockers in essential tremor. J Neurol 235(1):31-33
37. Jefferson D, Jenner P, Marsden CD (1979) Beta-adrenoreceptor antagonists in essential tremor. J Neurol Neurosurg Psychiatry 42(10):904-909
38. Abila B, Wilson JF, Marshall RW, Richens A (1985) The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment. Br J Clin Pharmacol 20(4):369-376
39. Larsen TA, Teravainen H (1981) Beta-blockers in essential tremor. Lancet 2(8245):533
40. Calzetti S, Findley LJ, Perucca E, Richens A (1982) Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. J Neurol Neurosurg Psychiatry 45(10):893-897
41. Cleeves L, Findley LJ (1984) Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist. J Neurol Neurosurg Psychiatry 47(9):976-982
42. Teravainen H, Huttunen J, Larsen TA (1986) Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor. Acta Neurol Scand 74(1):34-37
43. Jefferson D, Wharrad HJ, Birmingham AT, Patrick JM (1987) The comparative effects of ICI 118551 and propranolol on essential tremor. Br J Clin Pharmacol 24(6):729-734
44. Lee KS, Kim JS, Kim JW, Lee WY, Jeon BS, Kim D (2003) A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor. Parkinsonism Relat Disord 9(6):341-347
45. Koller WC (1985) Long-acting propranolol in essential tremor. Neurology 35(1):108-110
46. Cleeves L, Findley LJ (1988) Propranolol and propranolol-LA in essential tremor: a double-blind comparative study. J Neurol Neurosurg Psychiatry 51(3):379-384
47. Song IU, Kim JS, Lee SB, Ryu SY, An JY, Kim HT et al (2008) Effects of zonisamide on isolated head tremor. Eur J Neurol 15(11):1212-1215
48. Koller W, Graner D, Mlcoch A (1985) Essential voice tremor: treatment with propranolol. Neurology 35(1):106-108
49. Calzetti S, Sasso E, Negrotti A, Baratti M, Fava R (1992) Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration. Clin Neuropharmacol 15(6):470-476
50. Sweet RD, Blumberg J, Lee JE, Mc Dowell FH (1974) Propranolol treatment of essential tremor. Neurology 24(1):64-67
51. Jefferson D, Jenner P, Marsden CD (1979) Relationship between plasma propranolol concentration and relief of essential tremor. J Neurol Neurosurg Psychiatry 42(9):831-837
52. Baruzzi A, Procaccianti G, Martinelli P, Riva R, Denoth F, Montanaro N et al (1983) Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial. Neurology 33(3):296-300
53. Koller WC (1984) Propranolol therapy for essential tremor of the head. Neurology 34(8):1077-1079
54. Gorman WP, Cooper R, Pocock P, Campbell MJ (1986) A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry 49(1):64-68
55. Dietrichson P, Espen E (1987) Primidone and propranolol in essential tremor: a study based on quantitative tremor recording and plasma anticonvulsant levels. Acta Neurol Scand 75(5):332-340
56. O'Suilleabhain P, Dewey RB Jr (2002) Randomized trial comparing primidone initiation schedules for treating essential tremor. Mov Disord 17(2):382-386
57. Serrano-Dueñas M (2003) Use of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor: double-blind comparative study with one-year follow-up. Parkinsonism Rel Disord 10:29-33
58. Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA et al (2006) Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology 66(5):672-677
59. Bushara KO, Malik T, Exconde RE (2005) The effect of levetiracetam on essential tremor. Neurology 64(6):1078-1080
60. Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL (2007) A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor. Mov Disord 22(2):279-282
61. Huber SJ, Paulson GW (1988) Efficacy of alprazolam for essential tremor. Neurology 38(2):241-243
62. Thompson C, Lang A, Parkes JD, Marsden CD (1984) A double-blind trial of clonazepam in benign essential tremor. Clin Neuropharmacol 7(1):83-88
63. Zesiewicz TA, Ward CL, Hauser RA, Salemi JL, Siraj S, Wilson MC et al (2007) A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord 22(11):1660-1663
64. Melmed C, Moros D, Rutman H (2007) Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid). Mov Disord 22(5):723-727
65. Sasso E, Perucca E, Fava R, Calzetti S (1990) Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. Clin Neuropharmacol 13(1):67-76
66. Galvez-Jimenez N, Hargreave M (2000) Topiramate and essential tremor. Ann Neurol 47(6):837-838
67. Gatto EM, Roca MC, Raina G, Micheli F (2003) Low doses of topiramate are effective in essential tremor: a report of three cases. Clin Neuropharmacol 26(6):294-296
68. Ondo WG, Jimenez JE, Vuong KD, Jankovic J (2004) An open-label pilot study of levetiracetam for essential tremor. Clin Neuropharmacol 27(6):274-277
69. Sullivan KL, Hauser RA, Zesiewicz TA (2005) Levetiracetam for the treatment of essential tremor. Mov Disord 20(5):640
70. Sanz-Cartagena P, Fossas P, Floriach-Robert M, Serra-Prat M, Cano A, Palomeras E (2007) Effectiveness and safety of levetiracetam in patients with essential tremor: data from an open 11-week follow-up trial. Rev Neurol 45(3):134-136
71. Ondo WG (2007) Zonisamide for essential tremor. Clin Neuropharmacol 30(6):345-349
72. Bermejo PE (2007) Zonisamide in patients with essential tremor and Parkinson's disease. Mov Disord 22(14):2137-2138
73. Handforth A, Martin FC, Kang GA, Vanek Z (2009) Zonisamide for essential tremor: an evaluator-blinded study. Mov Disord 24(3):437-440
74. Lopez del Val LJ, Santos S (2003) Gabapentin in the treatment of tremor. Rev Neurol 36(4):322-326
75. O'Brien M, Upton A, Toseland P (1981) Benign familial tremor treated with primidone. Br Med J 282:178-180
76. Frima N, Grunewald RA (2006) A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor. Clin Neuropharmacol 29(2):94-96
77. Findley LJ, Calzetti S (1982) Double-blind controlled study of primidone in essential tremor: preliminary results. Br Med J (Clin Res Ed) 285(6342):608
78. Findley LJ, Cleeves L, Calzetti S (1985) Primidone in essential tremor of the hands and head: a double-blind controlled clinical study. J Neurol Neurosurg Psychiatry 48(9):911-915
79. Koller WC, Royse VL (1986) Efficacy of primidone in essential tremor. Neurology 36(1):121-124
80. Sasso E, Perucca E, Fava R, Calzetti S (1991) Quantitative comparison of barbiturates in essential hand and head tremor. Mov Disord 6(1):65-68
81. Milanov I (2002) Clinical and electromyographic assessment of essential tremor treatment. Parkinsonism Relat Disord 8(5):343-348
82. Sasso E, Perucca E, Calzetti S (1988) Double-blind comparison of primidone and phenobarbital in essential tremor. Neurology 38(5):808-810
83. Gunal DI, Afsar N, Bekiroglu N, Aktan S (2000) New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide. Neurol Sci 21(5):315-317
84. Connor GS, Edwards K, Tarsy D (2008) Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials. Clin Neuropharmacol 31(2):97-103
85. Morita S, Miwa H, Kondo T (2005) Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord 11(2):101-103
86. Ceravolo R, Salvetti S, Piccini P, Lucetti C, Gambaccini G, Bonuccelli U (1999) Acute and chronic effects of clozapine in essential tremor. Mov Disord 14(3):468-472
87. Yetimalar Y, Irtman G, Kurt T, Basoglu M (2005) Olanzapine versus propranolol in essential tremor. Clin Neurol Neurosurg 108(1):32-35
88. Pakkenberg H, Pakkenberg B (1986) Clozapine in the treatment of tremor. Acta Neurol Scand 73(3):295-297
89. Yetimalar Y, Irtman G, Gurgor N, Basoglu M (2003) Olanzapine efficacy in the treatment of essential tremor. Eur J Neurol 10(1):79-82
90. Micheli F, Cersosimo MG, Raina G, Gatto E (2002) Quetiapine and essential tremor. Clin Neuropharmacol 25(6):303-306
91. Gironell A, Kulisevsky J, Pascual-Sedano B, Flamarich D (2006) Effect of amantadine in essential tremor: a randomized, placebo-controlled trial. Mov Disord 21(4):441-445
92. Manyam BV (1981) Amantadine in essential tremor. Ann Neurol 9(2):198-199
93. Koller WC (1984) Amantadine in essential tremor. Ann Neurol 16(5):621-622
94. Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J (1996) A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 11(3):250-256
95. Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL et al (2001) A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 56(11):1523-1528
96. Pahwa R, Busenbark K, Swanson-Hyland EF, Dubinsky RM, Hubble JP, Gray C et al (1995) Botulinum toxin treatment of essential head tremor. Neurology 45(4):822-824
97. Warrick P, Dromey C, Irish JC, Durkin L, Pakiam A, Lang A (2000) Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection. Laryngoscope 110(8):1366-1374
98. Pacchetti C, Mancini F, Bulgheroni M, Zangaglia R, Cristina S, Sandrini G et al (2000) Botulinum toxin treatment for functional disability induced by essential tremor. Neurol Sci 21(6):349-353
99. Jankovic J, Schwartz K (1991) Botulinum toxin treatment of tremors. Neurology 41(8):1185-1188
100. Pullman SL, Greene P, Fahn S, Pedersen SF (1996) Approach to the treatment of limb disorders with botulinum toxin A: experience with 187 patients. Arch Neurol 53(7):617-624
101. Trosch RM, Pullman SL (1994) Botulinum toxin A injections for the treatment of hand tremors. Mov Disord 9(6):601-609
102. Hertegard S, Granqvist S, Lindestad PA (2000) Botulinum toxin injections for essential voice tremor. Ann Otol Rhinol Laryngol 109(2):204-209
103. Schuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, van Someren EJ, de Bie RM et al (2000) A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342(7):461-468
104. Schuurman PR, Bosch DA, Merkus MP, Speelman JD (2008) Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression. Mov Disord 23(8):1146-1153
105. Pahwa R, Lyons KE, Wilkinson SB, Troster AI, Overman J, Kieltyka J et al (2001) Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor. Mov Disord 16(1):140-143
106. Akbostanci MC, Slavin KV, Burchiel KJ (1999) Stereotactic ventral intermedial thalamotomy for the treatment of essential tremor: results of a series of 37 patients. Stereotact Funct Neurosurg 72(2-4):174-177
107. Nagaseki Y, Shibazaki T, Hirai T, Kawashima Y, Hirato M, Wada H et al (1986) Long-term follow-up results of selective VIM-thalamotomy. J Neurosurg 65(3):296-302
108. Mohadjer M, Goerke H, Milios E, Etou A, Mundinger F (1990) Long-term results of stereotaxy in the treatment of essential tremor. Stereotact Funct Neurosurg 54-55:125-129
109. Shahzadi S, Tasker RR, Lozano A (1995) Thalamotomy for essential and cerebellar tremor. Stereotact Funct Neurosurg 65(1-4):11-17
110. Goodman SH, Wilkinson S, Overman J, Koller WC, Troster A, Pahwa R et al (1998) Lesion volume and clinical outcome in stereotactic pallidotomy and thalamotomy. Stereotact Funct Neurosurg 71(4):164-172
111. Zirh A, Reich SG, Dougherty PM, Lenz FA (1999) Stereotactic thalamotomy in the treatment of essential tremor of the upper extremity: reassessment including a blinded measure of outcome. J Neurol Neurosurg Psychiatry 66(6):772-775
112. Young RJ, Jacques S, Mark R, Kopyov O, Copcutt B, Posewitz A, Li F (2000) Gamma knife thalamotomy for treatment of tremor: long-term results. J Neurosurg 93(Suppl 3):128-135
113. Ohye C, Shibazaki T, Zhang J, Andou Y (2002) Thalamic lesions produced by gamma thalamotomy for movement disorders. J Neurosurg 97(5 Suppl):600-606
114. Kondziolka D, Ong JG, Lee JY, Moore RY, Flickinger JC, Lunsford LD (2008) Gamma knife thalamotomy for essential tremor. J Neurosurg 108(1):111-117
115. Cooper SE, Kuncel AM, Wolgamuth BR, Rezai AR, Grill WM (2008) A model predicting optimal parameters for deep brain stimulation in essential tremor. J Clin Neurophysiol 25(5):265-273
116. Pahwa R, Lyons KL, Wilkinson SB, Carpenter MA, Troster AI, Searl JP et al (1999) Bilateral thalamic stimulation for the treatment of essential tremor. Neurology 53(7):1447-1450
117. Rehncrona S, Johnels B, Widner H, Tornqvist AL, Hariz M, Sydow O (2003) Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord 18(2):163-170
118. Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK (1998) Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology 51(4):1063-1069
119. Ondo W, Dat Vuong K, Almaguer M, Jankovic J, Simpson RK (2001) Thalamic deep brain stimulation: effects on the nontarget limbs. Mov Disord 16(6):1137-1142
120. Ondo W, Almaguer M, Jankovic J, Simpson RK (2001) Thalamic deep brain stimulation: comparison between unilateral and bilateral placement. Arch Neurol 58(2):218-222
121. Koller WC, Lyons KE, Wilkinson SB, Pahwa R (1999) Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor. Mov Disord 14(5):847-850
122. Hubble JP, Busenbark KL, Wilkinson S, Pahwa R, Paulson GW, Lyons K et al (1997) Effects of thalamic deep brain stimulation based on tremor type and diagnosis. Mov Disord 12(3):337-341
123. Koller WC, Lyons KE, Wilkinson SB, Troster AI, Pahwa R (2001) Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord 16(3):464-468
124. Koller W, Pahwa R, Busenbark K, Hubble J, Wilkinson S, Lang A et al (1997) High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 42(3):292-299
125. Benabid AL, Pollak P, Gao D, Hoffmann D, Limousin P, Gay E et al (1996) Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 84(2):203-214
126. Hubble JP, Busenbark KL, Wilkinson S, Penn RD, Lyons K, Koller WC (1996) Deep brain stimulation for essential tremor. Neurology 46(4):1150-1153
127. Hariz MS, Shamsgovara P, Johansson F, Hariz G, Fodstad H (1999) Tolerance and tremor rebound following long-term chronic thalamic stimulation for Parkinsonian and essential tremor. Stereotact Funct Neurosurg 72(2-4):208-218
128. Limousin PS, Speelman JD, Gielen F, Janssens M (1999) Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 66(3):289-296
129. Obwegeser AA, Uitti RJ, Turk MF, Strongosky AJ, Wharen RE (2000) Thalamic stimulation for the treatment of midline tremors in essential tremor patients. Neurology 54(12):2342-2344
130. Hariz GM, Lindberg M, Bergenheim AT (2002) Impact of thalamic deep brain stimulation on disability and health-related quality of life in patients with essential tremor. J Neurol Neurosurg Psychiatry 72(1):47-52
131. Sydow O, Thobois S, Alesch F, Speelman JD (2003) Multicentre European study of thalamic stimulation in essential tremor: a six-year follow-up. J Neurol Neurosurg Psychiatry 74(10):1387-1391
132. Putzke JD, Wharen RE Jr, Obwegeser AA, Wszolek ZK, Lucas JA, Turk MF et al (2004) Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis. Can J Neurol Sci 31(3):333-342
133. Ushe M, Mink JW, Revilla FJ, Wernle A, Schneider Gibson P, McGee-Minnich L et al (2004) Effect of stimulation frequency on tremor suppression in essential tremor. Mov Disord 19(10):1163-1168
134. Lee JY, Kondziolka D (2005) Thalamic deep brain stimulation for management of essential tremor. J Neurosurg 103(3):400-403
135. Ushe M, Mink JW, Tabbal SD, Hong M, Schneider Gibson P, Rich KM et al (2006) Postural tremor suppression is dependent on thalamic stimulation frequency. Mov Disord 21(8):1290-1292
136. Pahwa R, Lyons KE, Wilkinson SB, Simpson RK Jr, Ondo WG, Tarsy D et al (2006) Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg 104(4):506-512
137. Blomstedt P, Hariz GM, Hariz MI, Koskinen LO (2007) Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up. Br J Neurosurg 21(5):504-509
138. Pilitsis JG, Metman LV, Toleikis JR, Hughes LE, Sani SB, Bakay RA (2008) Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor. J Neurosurg 109(4):640-646
139. Hariz GM, Blomstedt P, Koskinen LO (2008) Long-term effect of deep brain stimulation for essential tremor on activities of daily living and health-related quality of life. Acta Neurol Scand 118(6):387-394
140. Taha JJ, Janszen MA, Favre J (1999) Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor. J Neurosurg 91(1):68-72
141. Tasker RR (1998) Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol 49(2):145-153 (discussion 153-144)
142. Kronenbuerger MF, Fromm C, Block F, Coenen VA, Rohde V, Noth J (2006) On-demand deep brain stimulation for essential tremor: a report on four cases. Mov Disord 21(3):401-405
143. Carpenter MA, Pahwa R, Miyawaki KL, Wilkinson SB, Searl JP, Koller WC (1998) Reduction in voice tremor under thalamic stimulation. Neurology 50(3):796-798
144. Blond S, Caparros-Lefebvre D, Parker F, Assaker R, Petit H, Guieu JD et al (1992) Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 77(1):62-68
145. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M et al (1991) Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337(8738):403-406
146. Kovacs N, Balas I, Illes Z, Kellenyi L, Doczi TP, Czopf J et al (2006) Uniform qualitative electrophysiological changes in postoperative rest tremor. Mov Disord 21(3):318-324
147. Duff J, Sime E (1997) Surgical interventions in the treatment of Parkinson's disease (PD) and essential tremor (ET): medial pallidotomy in PD and chronic deep brain stimulation (DBS) in PD and ET. Axone 18(4):85-89
148. Kumar KK, Kelly M, Toth C (1999) Deep brain stimulation of the ventral intermediate nucleus of the thalamus for control of tremors in Parkinson's disease and essential tremor. Stereotact Funct Neurosurg 72(1):47-61
149. Kuncel AM, Cooper SE, Wolgamuth BR, Clyde MA, Snyder SA, Montgomery EB Jr et al (2006) Clinical response to varying the stimulus parameters in deep brain stimulation for essential tremor. Mov Disord 21(11):1920-1928
150. O'Suilleabhain PE, Frawley W, Giller C, Dewey RB Jr (2003) Tremor response to polarity, voltage, pulsewidth and frequency of thalamic stimulation. Neurology 60(5):786-790
151. Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J (1993) Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) 58:39-44
152. Alesch F, Pinter MM, Helscher RJ, Fertl L, Benabid AL, Koos WT (1995) Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) 136(1-2):75-81
153. Plaha P, Patel NK, Gill SS (2004) Stimulation of the subthalamic region for essential tremor. J Neurosurg 101(1):48-54
154. Lind G, Schechtmann G, Lind C, Winter J, Meyerson BA, Linderoth B (2008) Subthalamic stimulation for essential tremor. Short- and long-term results and critical target area. Stereotact Funct Neurosurg 86(4):253-258
155. Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD et al (2000) Users guide to the medical literature XXV. Evidence-based medicine: principles for applying the users guides to patient care. J Am Med Assoc 284:1290-1296
156. Brainin M, Barnes M, Baron JC, Gilhus NS, Hughes R, Selmaj R et al (2004) Guidance for the preparation of neurological management guidelines by EFNS scientific task forces: revised recommendations 2004. Eur J Neurol 11:577-581
157. Morgan MH, Hewer RL, Cooper R (1973) Effect of the beta adrenergic blocking agent propranolol on essential tremor. J Neurol Neurosurg Psychiatry 36(4):618-624
158. Murray TJ (1976) Long-term therapy of essential tremor with propranolol. Can Med Assoc J 115(9):892-894
159. Koller WC, Biary N (1984) Effect of alcohol on tremors: comparison with propranolol. Neurology 34(2):221-222
160. Biary N, Koller W (1987) Kinetic predominant essential tremor: successful treatment with clonazepam. Neurology 37(3):471-474
161. Henderson JM, Yiannikas C, Morris JG, Einstein R, Jackson D, Byth K (1994) Postural tremor of Parkinson's disease. Clin Neuropharmacol 17(3):277-285
162. Jimenez-Jimenez FJ, Garcia-Ruiz PJ, Cabrera-Valdivia F (1994) Nicardipine versus propranolol in essential tumor. Acta Neurol (Napoli) 16(4):184-188
163. Mally J, Stone TW (1995) Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol. J Neurol Sci 132(2):129-132
164. Gironell A, Kulisevsky J, Barbanoj M, Lopez-Villegas D, Hernandez G, Pascual-Sedano B (1999) A randomized placebo-controlled comparative trial of
165. Leigh PN, Marsden CD, Twomey A, Jefferson D (1981) Beta-adrenoceptor antagonists and essential tremor. Lancet 1(8229):1106
166. Leigh PN, Jefferson D, Twomey A, Marsden CD (1983) Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol. J Neurol Neurosurg Psychiatry 46(8):710-715
167. Dietrichson P, Espen E (1981) Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recording. J Neurol Neurosurg Psychiatry 44(8):677-683
168. Koller WC (1983) Nadolol in essential tremor. Neurology 33(8):1076-1077
169. Handforth A, Martin FC (2004) Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor. Mov Disord 19(10):1215-1221
170. Elble RJ, Lyons KE, Pahwa R (2007) Levetiracetam is not effective for essential tremor. Clin Neuropharmacol 30(6):350-356
171. Pahwa R, Lyons K, Hubble JP, Busenbark K, Rienerth JD, Pahwa A et al (1998) Double-blind controlled trial of gabapentin in essential tremor. Mov Disord 13(3):465-467
172. Ondo W, Hunter C, Vuong KD, Schwartz K, Jankovic J (2000) Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord 15(4):678-682
173. Findley LJ, Cleeves L (1985) Phenobarbitone in essential tremor. Neurology 35(12):1784-1787
174. Ferrara J, Kenney C, Davidson A, Shinawi L, Kissel A, Jankovic J (2009) Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. J Neurol Sci 285:195-197
175. Mondrup K, Dupont E, Pedersen E (1983) The effect of the GABA-agonist, progabide, on benign essential tremor: a controlled clinical trial. Acta Neurol Scand 68(4):248-252
176. Koller W, Rubino F, Gupta S (1987) Pharmacological probe with progabide of GABA mechanism in essential tremor. 44:905-906